Yuri Furusawa

机构：National Institute of Infectious Diseases, National Center for Global Health and Medicine, The University of Tokyo · ORCID：0000-0002-7489-7303

发表论文 45 篇 · 总被引 3190 次 · h-index 18

代表论文

• Humoral immune evasion of the omicron subvariants BQ.1.1 and XBB (2022 · The Lancet Infectious Diseases · 被引 198)
• Antiviral and bivalent vaccine efficacy against an omicron XBB.1.5 isolate (2023 · The Lancet Infectious Diseases · 被引 112)
• Characterization of SARS-CoV-2 Omicron BA.4 and BA.5 isolates in rodents (2022 · Nature · 被引 111)
• In vitro and in vivo characterization of SARS-CoV-2 resistance to ensitrelvir (2023 · Nature Communications · 被引 85)
• In SARS-CoV-2 delta variants, Spike-P681R and D950N promote membrane fusion, Spike-P681R enhances spike cleavage, but neither substitution affects pathogenicity in hamsters (2023 · EBioMedicine · 被引 51)
• In vitro and in vivo characterization of SARS-CoV-2 strains resistant to nirmatrelvir (2023 · Nature Communications · 被引 48)